Evaluation shows vitamin C enriches green tea's antibacterial activity against pseudomonas aeruginosa, implying potential adjunctive therapy.
Pseudomonas aeruginosais a major antibiotic-resistant pathogen frequently associated with hospital-acquired infections posing significant treatment challenges. This study aimed to evaluate the antibacterial activity of the ethyl acetate fraction of green tea (Camellia sinensis L.) enriched with vitamin C against Pseudomonas aeruginosa. The ethyl acetate fraction obtained from 96% ethanol maceration was tested at concentrations of 12,5-200 mg/mL both with and without vitamin C using the disk diffusion method and compared to aztreonam as a positive control. Results showed that vitamin C enrichment increased the inhibition zone from 12,5 mm to 13,8 mm at 200 mg/mL, while aztreonam produced the largest inhibition zone at 20,17 mm. The vitamin C-enriched formulation also maintened antibacterical activity more effectively over a 5-15 day storage period. Vitamin C is believed to stabilize the primary antimicrobial compound epigallocatechin gallate (EGCG) by preventing its oxidation. These findings support the potential of vitamin C-enriched green tea extract as an adjunctive therapy against Pseudomonas aeruginosa infections. Further development of topical or systemic formulations is recommended for managing resistant bacterial infections.
No takes yet. Share an insight, caveat, or question.
Rayes et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: